GlassScriptPhysician profile
Melissa J Yanover
NPI 1518958008
$368.05
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.54 · 2021: $111 · 2022: $103 · 2023: $58.23 · 2024: $44.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $102.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $76.54 | 2021-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $65.47 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $53.83 | 2019-2024 | Jynarque |
| Fresenius USA Marketing, INC. | $40.97 | 2019-2022 | |
| Glaxosmithkline, LLC. | $35.64 | 2021 | |
| Ardelyx, INC. | $30.06 | 2024 | Ibsrela |
| Genentech, INC. | $27.52 | 2022 | |
| Outset Medical INC | $23.58 | 2023 | |
| Amgen INC. | $14.44 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Yanover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.